Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,930 DKK | -0.54% | -0.36% | -10.44% |
04/06 | Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating | MT |
03/06 | Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.44% | 1.8TCr | |
+18.72% | 12TCr | |
+14.19% | 11TCr | |
-4.93% | 2.42TCr | |
+3.23% | 2.28TCr | |
-41.74% | 1.64TCr | |
-13.31% | 1.64TCr | |
+2.44% | 1.36TCr | |
+27.89% | 1.17TCr | |
+83.45% | 916.57Cr |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S, Q1 2023 Earnings Call, May 10, 2023